Related Experiment Videos
[A patient with AIDS: infection associated with pneumocystis carinii and cryptococcus neoformans]
A Fica1, M Alamo, M Castrillón
1Departamento de Medicina, Facultad de Medicina, Universidad de Chile, Hospital J J Aguirre, Santiago de Chile.
Abstract:
A patient with AIDS developed pulmonary infiltrates typical of infection by P. carinii. However, therapy for this agent was unsuccessful. Further studies including blood cultures revealed the presence of C neoformans. Specific therapy for this agent led to recovery. Concomitant opportunistic infections may cause diagnostic and therapeutic problems in patients with AIDS.
Insights
A patient with Acquired Immunodeficiency Syndrome (AIDS) initially presented with Pneumocystis pneumonia symptoms. However, Cryptococcus neoformans was identified as the true pathogen, leading to successful treatment and recovery.
Area of Science:
- Infectious Diseases
- Immunology
- Pulmonology
Background:
- Patients with Acquired Immunodeficiency Syndrome (AIDS) are susceptible to opportunistic infections.
- Pneumocystis pneumonia (PCP) is a common opportunistic infection in AIDS patients.
- Accurate diagnosis is crucial for effective treatment of opportunistic infections in immunocompromised individuals.
Observation:
- A patient diagnosed with AIDS presented with pulmonary infiltrates characteristic of Pneumocystis pneumonia.
- Initial treatment targeting Pneumocystis jirovecii pneumonia was ineffective.
- Blood cultures subsequently identified Cryptococcus neoformans as the causative agent.
Findings:
- Cryptococcus neoformans was the actual pathogen responsible for the pulmonary infiltrates.
- Specific antifungal therapy targeting Cryptococcus neoformans led to the patient's recovery.
- The case highlights the potential for co-existing or misdiagnosed opportunistic infections in AIDS.
Implications:
- Concomitant opportunistic infections can complicate the diagnosis and management of AIDS patients.
- Diagnostic challenges necessitate comprehensive microbiological evaluation in refractory cases.
- Prompt and accurate identification of pathogens is vital for successful therapeutic outcomes in immunocompromised patients.